<h1>CCI Approves Canary and Link II's Acquisition of Less Than 5% in Intas Pharmaceuticals u/s 31(1) of Competition Act.</h1> The Competition Commission of India has approved the acquisition of a less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited and Link Investment Trust II. Canary is an investment company based in Mauritius, while Link II is a private trust registered in India. Intas Pharmaceuticals is a global pharmaceutical company involved in formulation development, manufacturing, and marketing. The approval is granted under Section 31(1) of the Competition Act, 2002, with the condition that Canary and Link II implement proposed modifications. A detailed order from the Commission will be issued subsequently.